Pharma Stan 50 - Pharmacom Labs

Introduced in the early 1960s, Stanozolol was approved by the FDA for treating anemia and muscle-wasting diseases. Marketed as Winstrol, it stood out for being a DHT-derivative with strong anabolic and low androgenic effects. In modern settings, it’s used by athletes to enhance definition without excess weight gain. Though milder than some steroids, it still suppresses endogenous testosterone, requiring PCT. Historically, it has remained one of the most recognized oral anabolic steroids in clinical and non-clinical use.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Pharma Stan 50 by Pharmacom Labs, consult with your doctor or healthcare professional.